- Trials with a EudraCT protocol (37)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
37 result(s) found for: Biological Process.
Displaying page 1 of 2.
EudraCT Number: 2016-004764-18 | Sponsor Protocol Number: 01-17 | Start Date*: 2017-07-24 |
Sponsor Name:St Patrick’s Mental Health Services | ||
Full Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004373-23 | Sponsor Protocol Number: ROV-BEM-2003-02 | Start Date*: 2007-08-14 | |||||||||||
Sponsor Name:LABORATORIOS FARMACEUTICOS ROVI, S.A. | |||||||||||||
Full Title: MULTICENTRIC, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND THE SAFETY OF THE PROPHYLAXIS WITH BEMIPARIN 3,500 IU/day FOR 28 DAYS COMPARED TO 8 DAYS, IN V... | |||||||||||||
Medical condition: VENOUS THROMBOEMBOLIC DISEASE IN PATIENTS UNDERGOING ONCOLOGICAL ABDOMINAL OR PELVIC SURGERY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002412-23 | Sponsor Protocol Number: DUO2022_01 | Start Date*: 2022-12-30 |
Sponsor Name:MB PHARMA s. r. o. | ||
Full Title: A prospective, randomized, double-blind, placebo-controlled Phase I/IIA Clinical Trial to demonstrate the safety and efficacy of DUOFAG® in bacterial infection treatment in patients with surgical w... | ||
Medical condition: Bacterial infection with Staphylococcus aureus and/or Pseudomonas aeruginosa in the surgical wound. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000041-40 | Sponsor Protocol Number: P131 | Start Date*: 2022-02-22 |
Sponsor Name:Maastricht University | ||
Full Title: A study to investigate the effects of repeated low doses of psilocybin and ketamine on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action | ||
Medical condition: Parkinson's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002020-37 | Sponsor Protocol Number: 20/15 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:St Patrick's Mental Health Services | |||||||||||||
Full Title: Ketamine for relapse prevention in recurrent depressive disorder: a randomised, controlled pilot trial | |||||||||||||
Medical condition: Recurrent depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006180-36 | Sponsor Protocol Number: 22071-24071 | Start Date*: 2011-01-18 | |||||||||||
Sponsor Name:EORTC - European Organisation for Research and Treatment of Cancer | |||||||||||||
Full Title: Randomized Phase III trial on postoperative chemoradiation in combination with anti EGFR-antibody versus postoperative chemoradiation in head and neck squamous cell carcinomas (HNSCC) with high ris... | |||||||||||||
Medical condition: head and neck squamous cell carcinomas (HNSCC) with high risk of locoregional recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) SI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004037-17 | Sponsor Protocol Number: 19_RIPH1_07 | Start Date*: 2021-07-28 | ||||||||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Martinique | ||||||||||||||||||
Full Title: Multicenter, randomized, open-label non-inferiority trial, comparing two antibiotic therapy periods (3 versus 7 days) in patients with mild leptospirosis and seen at the hospital in 5 French overse... | ||||||||||||||||||
Medical condition: Mild Leptospirosis : defined as Leptospirosis without the following severity criteria : a. Hemodynamic failure* with onset of septic shock b. Hematologic failure* with hemoglobin requiring red blo... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001372-66 | Sponsor Protocol Number: TACmono-100 | Start Date*: 2014-07-16 |
Sponsor Name:Erasmus Medical Center | ||
Full Title: Tacrolimus monotherapy in immunologically low-risk kidney transplant recipients: a pilot randomized-controlled study. | ||
Medical condition: kidney transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004169-18 | Sponsor Protocol Number: Sat-CIEN-02 | Start Date*: 2017-02-22 | |||||||||||
Sponsor Name:Centro de Investigación Biomédica en Red, Enfermedades Neurodegenerativas (CIBERNED) | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, 4-arm, 26 week parallel-group study to evaluate the safety, tolerability and anti-inflammatory effect of three oromucosal doses of Sativ... | |||||||||||||
Medical condition: Patients with mild cognitive impairment of Alzheimer type or early Alzheimer dementia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000431-32 | Sponsor Protocol Number: ORTHOUNION | Start Date*: 2017-05-25 | ||||||||||||||||
Sponsor Name:Universidad Autónoma de Madrid (U.A.M.) | ||||||||||||||||||
Full Title: A MULTI-CENTRE, OPEN-LABEL, RANDOMIZED, COMPARATIVE CLINICAL TRIAL OF TWO DIFFERENT DOSES OF BONE MARROW AUTOLOGOUS HUMAN MESENCHYMAL STEM CELLS PLUS BIOMATERIAL VERSUS ILIAC CREST AUTOLOGOUS GRAFT... | ||||||||||||||||||
Medical condition: Diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) with status of non-union | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) FR (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000634-34 | Sponsor Protocol Number: 13704501 | Start Date*: 2014-05-19 |
Sponsor Name:CHU Toulouse | ||
Full Title: IFM 2014-02 study: A randomized phase III study of Bortezomib-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma | ||
Medical condition: Multiple Myeloma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001327-23 | Sponsor Protocol Number: ITP0815 | Start Date*: 2015-06-26 | |||||||||||
Sponsor Name:Fondazione G.I.M.EM.A. Gruppo Italiano Malattie Ematologiche dell'Adulto | |||||||||||||
Full Title: Eltrombopag as Second line Therapy in adult patients with primary Immune Thrombocytopenia (ESTIT study) in an attempt to achieve long-term remission: a single arm multicenter phase II clinical and ... | |||||||||||||
Medical condition: Primary Immune Thrombocytopenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003388-39 | Sponsor Protocol Number: KDO_DC1311 | Start Date*: 2015-03-26 |
Sponsor Name:Masarykova univerzita | ||
Full Title: COMBINED ANTITUMOR THERAPY WITH EX VIVO MANIPULATED DENDRITIC CELLS PRODUCING INTERLEUKIN-12 IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH PROGRESSIVE, RECURRENT OR PRIMARILY METASTATIC HIGH-RISK ... | ||
Medical condition: Progressive, recurrent or primarily metastatic high-risk malignities | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006445-41 | Sponsor Protocol Number: CTSSTS1010207V2 | Start Date*: 2012-01-28 | |||||||||||
Sponsor Name:HEALTH RICERCAE SVILUPPO SRL | |||||||||||||
Full Title: The irreversibility of hemorrhagic shock treatment with anti-opiod neuropeptide | |||||||||||||
Medical condition: Mortality of hemorrhagic shock grade 2 and 3 is from 50 to '80% in the first 24 hours, and morbidity and mortality betrayed is to 7 to 8 days of' 90% for Acute Respiratory Distress Syndrome and / o... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001760-30 | Sponsor Protocol Number: AR/BIOM | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:OSSERVATORIO EPIDEMIOLOGICO GISEA | |||||||||||||
Full Title: Evaluation effects of treatment with IL-6R inhibitor on clinical response and biomarkers in patients with rheumatoid arthritis (RA) not responding to DMARDs and/or a first biological agent. | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002071-29 | Sponsor Protocol Number: ITT012“ELISA” | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:DIPARTIMENTO DI ONCOLOGIA MEDICA USL8 | |||||||||||||
Full Title: A RANDOMIZED PROSPECTIVE MULTICENTRE PHASE II STUDY OF ANDROGEN DEPRIVATION THERAPY (ADT) PLUS RADIOTHERAPY WITH OR WITHOUT ABIRATERONE ACETATE AND PREDNISONE IN LOCALLY ADVANCED VERY HIGH-RISK PRO... | |||||||||||||
Medical condition: LOCALLY ADVANCED VERY HIGH-RISK PROSTATE CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002241-39 | Sponsor Protocol Number: BO 18192 | Start Date*: 2005-11-09 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: A multicentre, double-blind randomised, phase III study to evaluate the efficacy of Tarceva or placebo following 4 cycles of platinum-based chemotherapy in patients with histologically documented a... | ||
Medical condition: Advanced (stage IIIB or IV) NSCLC previously treated with 4 cycles of a platinum-based chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) ES (Completed) SI (Completed) GB (Completed) AT (Completed) LT (Completed) SK (Completed) PT (Prematurely Ended) DE (Completed) DK (Completed) CZ (Completed) IT (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002123-15 | Sponsor Protocol Number: GEICAM/2019-01 | Start Date*: 2020-06-15 | |||||||||||
Sponsor Name:GEICAM (Fundación Grupo Español de Investigación en Cáncer de Mama) | |||||||||||||
Full Title: Phase II, randomized, open-label, international, multicenter study to compare efficacy of standard chemotherapy vs. letrozole plus abemaciclib as neoadjuvant therapy in HR-positive/HER2-negative hi... | |||||||||||||
Medical condition: High/intermediate risk hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer patients with indication of neoadjuvant therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007996-26 | Sponsor Protocol Number: RC 47/07 | Start Date*: 2008-12-15 | |||||||||||
Sponsor Name:ISTITUTO PER L`INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Comparison between wound infiltration with different ropivacaine concentrations following inguinal herniotomy for postoperative analgesia in children: a randomized, double-blind, placebo-controlle... | |||||||||||||
Medical condition: Children ASA 1-2, aged 1 to 8 years. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002443-26 | Sponsor Protocol Number: OVG2012/04 | Start Date*: 2012-08-17 |
Sponsor Name:University of Oxford | ||
Full Title: A phase II, multi-centre, open labelled randomised control trial to describe immune & transcriptomic responses to trivalent inactivated vaccine (TIV) & MF59 adjuvanted influenza vaccine (ATIV) in 1... | ||
Medical condition: Healthy children will be immunised with two vaccines against influenza: Agrippal or Imuvac, or Fluad to study the immune responses to immunisation at a genetic level. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.